Novo Nordisk AS (NVO)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$41.12
Buy
$41.15
$0.05 (+0.12%)
Prices updated at 18 Sep 2026, 11:15 EDT
| Prices minimum 15 mins delay
Prices in USD
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| $43.54 - $42.78 | |
| $64.16 - $35.12 | |
| 3.96 | |
| 190,927.23m | |
| 10.74 | |
| - | |
| 1,768,253 | |
| 5.63 | |
| 16,315,738.88 | |
| 1.14 | |
| 4,465.00m | |
| US6701002056 | |
| 23.03 | |
| - |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.